Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study.
| Autor: | Abdelaziz, Lobna A.1 mmlobna90@gmail.com, Taha, Heba F.2, Ali, Magid M.3, Abdelgawad, Marwa I.4, Elwan, Amira1 |
|---|---|
| Zdroj: | Contemporary Oncology / Współczesna Onkologia. 2020, Vol. 24 Issue 4, p221-228. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|